FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application

NCT06270394 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Malignant Tumors
Positron-Emission Tomography

Interventions

DRUG: 68Ga-Fibroblast activation protein inhibitor

Sponsor

The First Affiliated Hospital of Anhui Medical University

Collaborators

[object Object]